Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647046 · ClinicalTrials.gov registry record · NA
Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03647046 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 12 participants.
The verdict
NCT03647046, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of the study is to examine the effects of custom front-surface wavefront correction on visual performance, and on neutralization of higher order aberrations, in patients wearing a scleral lens device. The investigators will study patients with keratoconus, the most common type of corneal ectasia, who have already been fitted with the BostonSight BSS (Boston Sight Scleral) for improved visual function.
Interventions
- DEVICE Customized Scleral Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2020-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03647046
The ClinicalTrials.gov registry entry for NCT03647046 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Customized Scleral Lens is the first listed.
NCT03647046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03647046 about?
NCT03647046 is a clinical study titled "Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus". The goal of the study is to examine the effects of custom front-surface wavefront correction on visual performance, and on neutralization of higher order aberrations, in patients wearing a scleral lens device. The investigators will study patients with keratoconus, the most common type of corneal ec...
What is the current status of trial NCT03647046?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-10-08. Estimated completion is 2020-01-20.
What interventions are being tested in trial NCT03647046?
The interventions under investigation include: Customized Scleral Lens (DEVICE).
Who is sponsoring clinical trial NCT03647046?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.